Blockchain-Authenticated Sharing of Genomic and Clinical Outcomes Data of Patients With Cancer: A Prospective Cohort Study
Published version of a preprint
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background: Efficiently sharing health data produced during standard care could dramatically accelerate progress in cancer treatments, but various barriers make this difficult. Not sharing these data to ensure patient privacy is at the cost of little to no learning from real-world data produced during cancer care. Furthermore, recent research has demonstrated a willingness of patients with cancer to share their treatment experiences to fuel research, despite potential risks to privacy. Objective: The objective of this study was to design, pilot, and release a decentralized, scalable, efficient, economical, and secure strategy for the dissemination of deidentified clinical and genomic data with a focus on late-stage cancer. Methods: We created and piloted a blockchain-authenticated system to enable secure sharing of deidentified patient data derived from standard of care imaging, genomic testing, and electronic health records (EHRs), called the Cancer Gene Trust (CGT). We prospectively consented and collected data for a pilot cohort (N=18), which we uploaded to the CGT. EHR data were extracted from both a hospital cancer registry and a common data model (CDM) format to identify optimal data extraction and dissemination practices. Specifically, we scored and compared the level of completeness between two EHR data extraction formats against the gold standard source documentation for patients with available data (n=17). Results: Although the total completeness scores were greater for the registry reports than those for the CDM, this difference was not statistically significant. We did find that some specific data fields, such as histology site, were better captured using the registry reports, which can be used to improve the continually adapting CDM. In terms of the overall pilot study, we found that CGT enables rapid integration of real-world data of patients with cancer in a more clinically useful time frame. We also developed an open-source Web application to allow users to seamlessly search, browse, explore, and download CGT data. Conclusions: Our pilot demonstrates the willingness of patients with cancer to participate in data sharing and how blockchain-enabled structures can maintain relationships between individual data elements while preserving patient privacy, empowering findings by third-party researchers and clinicians. We demonstrate the feasibility of CGT as a framework to share health data trapped in silos to further cancer research. Further studies to optimize data representation, stream, and integrity are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nine higher-maturity studies examined applications of blockchain/DLT systems in clinical trials/research governance [36-44].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [42]
In the citing paper
“Additional applications included monitoring changes to medical records [41], authenticated sharing of deidentified genomic and clinical cancer data [42], decentralized biobanking [43], and patient-facing access to health records and research eligibility information [44].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [42]
In the citing paper
“In line with this, systems in which the ledger was most central did not reach sustained use [27,28,31,32,37-45].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [42]
In the citing paper
“Additionally, this study demonstrates that the specific contribution of DLT properties to measured outcomes could generally not be isolated from that of interface design, system integration, and conventional infrastructure [27,28,31,32,37-45].”
From Blockchain for Digital Health Governance: Evidence Gap Map and Scoping Review (2026) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frampton, G. M., Fichtenholtz, A., Otto, G. A., Wang, K., Downing, S. R., He, J., Schnall-Levin, M., White, J., Sanford, E. M., An, P., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2696 · Cited by 2,157 · cited 1×
“…sequencing of tumor specimens was ordered by the supervising physician (EC) as standard of care using either a commercial (Foundation Medicine; FMI [28]) or in-house panel (UCSF 500) [29]; 13 patients were sequenced and analyzed by Foundation Medicine [30] and 4 patients by the UCSF 500 [31]…”
MethodEstimating the success of re-identifications in incomplete datasets using generative models
Rocher, L., Hendrickx, J. M., & de Montjoye, Y.-A. (2019) · Nature Communications · doi:10.1038/s41467-019-10933-3 · Cited by 816
Fhirchain: applying blockchain to securely and scalably share clinical data
Zhang, P., White, J., Schmidt, D. C., Lenz, G., & Rosenbloom, S. T. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.07.004 · Cited by 796
Mamoshina, P., Ojomoko, L., Yanovich, Y., Ostrovski, A., Botezatu, A., Prikhodko, P., Izumchenko, E., Aliper, A., Romantsov, K., Zhebrak, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.22345 · Cited by 471
Stang, P. E., Ryan, P. B., Racoosin, J. A., Overhage, J. M., Hartzema, A. G., Reich, C., Welebob, E., Scarnecchia, T., & Woodcock, J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00010 · Cited by 441 · cited 1×
“The OMOP CDM is emerging as a standard in the field of EHR research because it is a common framework in terms of both table structure and underlying vocabulary [32] and has enabled powerful research and a venue for regulatory reporting [33].”
MethodAgniel, D., Kohane, I. S., & Weber, G. M. (2018) · BMJ · doi:10.1136/bmj.k1479 · Cited by 391
Clinical Trial Participants’ Views of the Risks and Benefits of Data Sharing
Mello, M. M., Lieou, V., & Goodman, S. N. (2018) · New England Journal of Medicine · doi:10.1056/nejmsa1713258 · Cited by 237 · cited 3×
“Many patients with cancer, however, are willing to share their data and believe that the positive benefits outweigh the potential privacy risks: 93% of patients surveyed would be very or somewhat likely to share their data with university scientists [9].”
BackgroundInfluentialPrototype of running clinical trials in an untrustworthy environment using blockchain
Wong, D. R., Bhattacharya, S., & Butte, A. J. (2019) · Nature Communications · doi:10.1038/s41467-019-08874-y · Cited by 160 · cited 1×
“Multiple publications have proposed the utility of blockchain technology for secure and scalable clinical data sharing [15-19], and many companies and organizations are applying blockchain platforms in health care [20].”
BackgroundRealizing the potential of blockchain technologies in genomics
Ozercan, H. I., Ileri, A. M., Ayday, E., & Alkan, C. (2018) · Genome Research · doi:10.1101/gr.207464.116 · Cited by 143
Glicksberg, B. S., Oskotsky, B., Thangaraj, P. M., Giangreco, N., Badgeley, M. A., Johnson, K. W., Datta, D., Rudrapatna, V. A., Rappoport, N., Shervey, M. M., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz409 · Cited by 45 · cited 1×
“This application, called PatientExploreR-CGT, is adapted from our original PatientExploreR version [37].”
MethodSelf-citation
Research works printed but not linked: 21
- 10.1038/nrd3181 · DOI · Paper page
- 10.1126/science.1226344 · DOI · Paper page
- 10.1056/NEJMsb1609216 · DOI · Paper page
- 10.1093/hmg/ddy114 · DOI · Paper page
- 10.1038/s41591-018-0320-3 · DOI · Paper page
- 10.1186/s12916-017-0935-0 · DOI
- 10.1377/hlthaff.2017.1579 · DOI · Paper page
- 10.1001/jama.2012.525 · DOI
- 10.1161/CIRCOUTCOMES.118.005122 · DOI · Paper page
- 10.1016/j.cell.2017.10.032 · doi:10.1016/j.cell.2017.10.032
- 10.1001/jama.2019.3241 · DOI · Paper page
- 10.2196/13600 · DOI
- Dubovitskaya, A, 2017, AMIA Annu Symp Proc, 2017, 650
- 10.1093/jamia/ocy185 · DOI · Paper page
- 10.2196/12533 · DOI
- 10.2196/12439 · DOI · Paper page
- 10.1038/modpathol.2016.188 · DOI
- 10.1093/neuonc/now254 · DOI · Paper page
- 10.1093/jamiaopen/ooy059 · DOI
- 10.1038/sdata.2016.35 · DOI · Paper page
- 10.1016/j.jbi.2019.103253 · DOI · Paper page
Cited by
Navigating Challenges and Opportunities in Multi-Omics Integration for Personalized Healthcare
Mohr, A. E., Ortega-Santos, C. P., Whisner, C. M., Klein-Seetharaman, J., & Jasbi, P. (2024) · Biomedicines · doi:10.3390/biomedicines12071496 · Cited by 311
“Such secured sharing events have been piloted in cancer patients with deidentified patient data derived from standard-of-care imaging, genomic testing, and electronic health records in a blockchain environment [141].”
BackgroundSharing Biomedical Data: Strengthening AI Development in Healthcare
Pereira, T., Morgado, J., Silva, F., Pelter, M. M., Dias, V. R., Barros, R., Freitas, C., Negrão, E., Flor de Lima, B., Correia da Silva, M., et al. (2021) · Healthcare · doi:10.3390/healthcare9070827 · Cited by 54
“Although this technology is still more associated with the financial area [43], nowadays, there are many pilot projects currently underway, such as FHIRChain [44], Cancer Gene Trust [45], and Zenome [46].”
BackgroundBlockchain for Digital Health Governance: Evidence Gap Map and Scoping Review
Yaghobian, S., Sulkowski, N., Galambos, G., Scarazzini, L., Maloumian, N., & Verhaeghe, S. (2026) · Journal of Medical Internet Research · doi:10.2196/96098 · Cited by 1
Metadata
- Authors
- Glicksberg, B. S., Burns, S., Currie, R., Griffin, A., Wang, Z. J., Haussler, D., Goldstein, T., & Collisson, E.
- ORCID
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2020-03-20
- Volume
- 22
- Issue
- 3
- Pages
- e16810
- ISSN
- 1438-8871
- Cited by
- 51
- References
- 10
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.